The top five pathways in the pathway enrichment analysis were VEGF signaling, adipocyte lipolysis regulation, chronic myelogenous leukemia, endocrine resistance, and NSCLC. The gene discussed is VEGFA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.